Table 2.

Multivariate associations of neuropathy and demographic and cancer-related factors with falls in cancer patients with chemotherapy-induced peripheral neuropathy

Predictor	Estimated adjusted OR
	OR	95% CI		P
Age: >65 vs. <65 yearsa	0.748	0.192	2.905	0.675
Educational level: ≤ high school vs. ≥college	0.361	0.103	1.269	0.112
Employment: Unemployed vs. employed	1.162	0.399	3.379	0.783
Metastasis: Yes vs. no	0.139	0.008	2.507	0.181
Total dose of taxane anticancer agents	0.999	0.999	1.000	0.296
NCI-CTCAE vs. 4.0 grade: >2 vs. 1	4.012	0.831	19.372	0.084
Total score of FACT/GOG-NTX	0.962	0.903	1.025	0.232
Frequency of any functional impairment: Yes vs. nob	1.528	0.434	5.386	0.509

^a≥65 years=0, <65 years=1, ^bYes>1. NCI-CTCAE: National Cancer Institute Common Terminology Criteria for Adverse Events, FACT/GOG-NTX: Functional Assessment of Cancer Therapy-Gynecologic Oncology Group-Neurotoxicity, OR: Odds ratio, CI: Confidence interval